Ukraine’s new Health Minister outlines priorities at meeting with APRAD

22 December 2014

At the instance of Association of Pharmaceutical Research and Development (APRAD), the Ministry of Health of Ukraine (MoH) held an official meeting with the international research-based pharmaceutical industry to discuss further cooperation as a part of essential health care reform.

A high level meeting took place earlier this month with the participation of a newly-appointed Minister of Health of Ukraine, Oleksandr Kvitashvili, Deputy MoH Minister on European Union integration issues, Yuriy Savko, Head of MoH International Department, Inna Golovanchuk, and the international research-based pharmaceutical industry represented by the APRAD and the European Federation of Pharmaceutical Industries and Associations (EFPIA).

During the discussions the Health Minister emphasized that among priorities of upcoming reforms are the following:

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

More ones to watch >